Zevra Therapeutics Inc
ZVRA
Company Profile
Business description
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Contact
101 Federal Street
BostonMA02110
USAT: +1 888 958-1253
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
61
Stocks News & Analysis
stocks
Margins have bottomed for ASX listed consumer goods company
Impact of tariffs have been priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,008.40 | 41.30 | -0.46% |
| CAC 40 | 8,400.11 | 21.03 | -0.25% |
| DAX 40 | 25,139.69 | 153.87 | 0.62% |
| Dow JONES (US) | 51,712.71 | 148.01 | 0.29% |
| FTSE 100 | 10,437.85 | 74.58 | 0.72% |
| HKSE | 23,492.31 | 276.21 | -1.16% |
| NASDAQ | 26,166.60 | 351.33 | -1.32% |
| Nikkei 225 | 71,429.07 | 924.89 | -1.28% |
| NZX 50 Index | 13,456.71 | 10.66 | 0.08% |
| S&P 500 | 7,472.79 | 27.79 | -0.37% |
| S&P/ASX 200 | 8,805.50 | 29.60 | -0.34% |
| SSE Composite Index | 4,147.55 | 15.55 | -0.37% |